Literature DB >> 12568610

Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.

Cristina Chiva1, Philippe Barthe, Anna Codina, Margarida Gairí, Franck Molina, Claude Granier, Martine Pugnière, Tatsuya Inui, Hideki Nishio, Yuji Nishiuchi, Terutoshi Kimura, Shumpei Sakakibara, Fernando Albericio, Ernest Giralt.   

Abstract

The total synthesis and structural characterization of the MHCII-associated p41 invariant chain fragment (P41icf) is described. P41icf plays a crucial role in the maturation of MHC class II molecules and antigen processing, acting as a highly selective cathepsin L inhibitor. P41icf synthesis was achieved using a combined solid-phase/solution approach. The entire molecule (65 residues, 7246 Da unprotected) was assembled in solution from fully protected peptides in the size range of 10 residues. After deprotection, oxidative folding in carefully adjusted experimental conditions led to the completely folded and functional P41icf with a disulfide pairing identical to that of native P41icf. CD, NMR, and surface plasmon resonance (SPR) were used for the structural and functional characterization of synthetic P41icf. CD thermal denaturation showed clear cooperative behavior. Tight cathepsin L binding was demonstrated by SPR. (1)H NMR spectroscopy at 800 MHz of unlabeled P41icf was used to solve the three-dimensional structure of the molecule. P41icf behaves as a well-folded protein domain with a topology very close to the crystallographic cathepsin L-bound form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568610     DOI: 10.1021/ja0207908

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  ENPDA: an evolutionary structure-based de novo peptide design algorithm.

Authors:  Ignasi Belda; Sergio Madurga; Xavier Llorà; Marc Martinell; Teresa Tarragó; Mireia G Piqueras; Ernesto Nicolás; Ernest Giralt
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

Review 2.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

3.  Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor.

Authors:  Michael C Myers; Parag P Shah; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-11-01       Impact factor: 2.823

4.  Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy.

Authors:  Gregory M Lee; Eaman Balouch; David H Goetz; Ana Lazic; James H McKerrow; Charles S Craik
Journal:  Biochemistry       Date:  2012-12-10       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.